US Patent 7816491 Ordered biological nanostructures formed from chaperonin polypeptides
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+335 characters)
Article
Patent abstract
The following application relates to nanotemplates, nanostructures, nanoarrays and nanodevices formed from wild-type and mutated chaperonin polypeptides, methods of producing such compositions, methods of using such compositions and particular chaperonin polypeptides that can be utilized in producing such compositions.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07816491 Ordered biological nanostructures formed from chaperonin polypeptides US Patent 7816491 Ordered biological nanostructures formed from chaperonin polypeptides
Infobox
Patent Number
0781649100
Patent Number
781649100
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078164910
Date of Patent
October 19, 2010
0Patent Application Number
104948530
Date Filed
November 8, 2002
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078164910
Date of Patent
October 19, 2010
0Patent Application Number
104948530
Date Filed
November 8, 2002
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07816491 Ordered biological nanostructures formed from chaperonin polypeptides
Infobox
Is a
Patent jurisdiction
Patent number
07816491
Date of patent
October 19, 2010
Patent application number
10494853
Date Filed
November 8, 2002
Patent primary examiner
Find more entities like US Patent 7816491 Ordered biological nanostructures formed from chaperonin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.